Associations Among Disease Conditions, Bone Mineral Density, and Prevalent Vertebral Deformities in Men and Women 50 Years of Age and Older: Cross‐Sectional Results From the Canadian Multicentre Osteoporosis Study

This cross‐sectional cohort study of 5566 women and 2187 men 50 years of age and older in the population‐based Canadian Multicentre Osteoporosis Study was conducted to determine whether reported past diseases are associated with bone mineral density or prevalent vertebral deformities. We examined 12 self‐reported disease conditions including diabetes mellitus (types 1 or 2), nephrolithiasis, hypertension, heart attack, rheumatoid arthritis, thyroid disease, breast cancer, inflammatory bowel disease, neuromuscular disease, Paget's disease, and chronic obstructive pulmonary disease. Multivariate linear and logistic regression analyses were performed to determine whether there were associations among these disease conditions and bone mineral density of the lumbar spine, femoral neck, and trochanter, as well as prevalent vertebral deformities. Bone mineral density measurements were higher in women and men with type 2 diabetes compared with those without after appropriate adjustments. The differences were most notable at the lumbar spine (+0.053 g/cm2), femoral neck (+0.028 g/cm2), and trochanter (+0.025 g/cm2) in women, and at the femoral neck (+0.025 g/cm2) in men. Hypertension was also associated with higher bone mineral density measurements for both women and men. The differences were most pronounced at the lumbar spine (+0.022 g/cm2) and femoral neck (+0.007 g/cm2) in women and at the lumbar spine (+0.028 g/cm2) in men. Although results were statistically inconclusive, men reporting versus not reporting past nephrolithiasis appeared to have clinically relevant lower bone mineral density values. Bone mineral density differences were −0.022, −0.015, and −0.016 g/cm2 at the lumbar spine, femoral neck, and trochanter, respectively. Disease conditions were not strongly associated with vertebral deformities. In summary, these cross‐sectional population‐based data show that type 2 diabetes and hypertension are associated with higher bone mineral density in women and men, and nephrolithiasis may be associated with lower bone mineral density in men. The importance of these associations for osteoporosis case finding and management require further and prospective studies.

[1]  R. Nespoli,et al.  A study of dietary calcium and other nutrients in idiopathic renal calcium stone formers with low bone mineral content. , 1998, The Journal of urology.

[2]  H. Yki-Järvinen Pathogenesis of non-insulin-dependent diabetes mellitus , 1994, The Lancet.

[3]  S. A. Jackson,et al.  Vertebral Fracture Definition from Population-Based Data: Preliminary Results from the Canadian Multicenter Osteoporosis Study (CaMos) , 2000, Osteoporosis International.

[4]  J. Hopper,et al.  Risk factors for osteoporosis , 1989, Osteoporosis International.

[5]  Breslau Na Pathogenesis and management of hypercalciuric nephrolithiasis. , 1994 .

[6]  Jacques P. Brown,et al.  Research Notes: The Canadian Multicentre Osteoporosis Study (CaMos): Background, Rationale, Methods , 1999, Canadian Journal on Aging / La Revue canadienne du vieillissement.

[7]  K. Birkeland,et al.  Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes. , 1993, The Journal of clinical endocrinology and metabolism.

[8]  M. Evans,et al.  Clinical practice guidelines for the diagnosis and management of osteoporosis , 1997 .

[9]  P. Wolf,et al.  The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. , 1994, American journal of public health.

[10]  S. Silverman,et al.  Deterioration in Quality of Life Following Hip Fracture: A Prospective Study , 2000, Osteoporosis International.

[11]  K. Khaw,et al.  Sex hormones and bone mineral density in elderly men. , 1993, Bone and mineral.

[12]  S. Cummings,et al.  Older women with diabetes have an increased risk of fracture: a prospective study. , 2001, The Journal of clinical endocrinology and metabolism.

[13]  A. Hofman,et al.  Bone Density in Non-Insulin-Dependent Diabetes Mellitus: The Rotterdam Study , 1995, Annals of Internal Medicine.

[14]  S. Cummings,et al.  Factors Associated with Appendicular Bone Mass in Older Women , 1993, Annals of Internal Medicine.

[15]  J. Casez,et al.  Low bone mass in idiopathic renal stone formers: Magnitude and significance , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  K. Lau,et al.  Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. , 1990, The Journal of clinical endocrinology and metabolism.

[17]  T. Clemens,et al.  Bone mineral density in women with type II diabetes mellitus , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  N. Breslau Pathogenesis and management of hypercalciuric nephrolithiasis. , 1994, Mineral and electrolyte metabolism.

[19]  R. Lindsay Why do oestrogens prevent bone loss? , 1991, Bailliere's clinical obstetrics and gynaecology.

[20]  G. Hortobagyi,et al.  Pilot study of bone mineral density in breast cancer patients treated with adjuvant chemotherapy. , 1998, Cancer investigation.

[21]  T. Pepersack,et al.  Low calcium diet in idiopathic urolithiasis: a risk factor for osteopenia as great as in primary hyperparathyroidism. , 1990, British journal of urology.

[22]  R. Lindsay 5 Why do oestrogens prevent bone loss , 1991 .

[23]  I. Heilberg,et al.  Bone disease in calcium stone forming patients. , 1994, Clinical nephrology.

[24]  D. Bauer,et al.  Axial Bone Mass in Older Women , 1996, Annals of Internal Medicine.

[25]  P. Delmas,et al.  Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  C. Cooper,et al.  Health‐Related Quality of Life in Postmenopausal Women With Low BMD With or Without Prevalent Vertebral Fractures , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  Lawrence Joseph,et al.  Multiple Imputation to Account for Missing Data in a Survey: Estimating the Prevalence of Osteoporosis , 2002, Epidemiology.

[28]  B. Reed,et al.  Mapping a gene defect in absorptive hypercalciuria to chromosome 1q23.3-q24. , 1999, The Journal of clinical endocrinology and metabolism.

[29]  L. Kuller,et al.  Determinants of bone mineral density in older men , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.